159 related articles for article (PubMed ID: 2895789)
1. Thy-1- and Ly-6-mediated lymphokine production and growth inhibition of a T cell hybridoma require co-expression of the T cell antigen receptor complex.
Sussman JJ; Saito T; Shevach EM; Germain RN; Ashwell JD
J Immunol; 1988 Apr; 140(8):2520-6. PubMed ID: 2895789
[TBL] [Abstract][Full Text] [Related]
2. Defects in signal transduction caused by a T cell receptor beta chain substitution.
Reno TA; Ley S; Sugiyama E; Cantagrel A; Blumberg R; Bonventre J; Terhorst C; Yeh ET
Eur J Immunol; 1990 Jul; 20(7):1417-22. PubMed ID: 1696890
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules.
Merćep M; Bluestone JA; Noguchi PD; Ashwell JD
J Immunol; 1988 Jan; 140(1):324-35. PubMed ID: 2891766
[TBL] [Abstract][Full Text] [Related]
4. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor.
Bockenstedt LK; Goldsmith MA; Dustin M; Olive D; Springer TA; Weiss A
J Immunol; 1988 Sep; 141(6):1904-11. PubMed ID: 2459194
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of IL-2 production by activation of T cells through Ly-6A/E.
Codias EK; Rutter JE; Fleming TJ; Malek TR
J Immunol; 1990 Sep; 145(5):1407-14. PubMed ID: 2143518
[TBL] [Abstract][Full Text] [Related]
6. Thy-1-mediated T-cell activation requires co-expression of CD3/Ti complex.
Gunter KC; Germain RN; Kroczek RA; Saito T; Yokoyama WM; Chan C; Weiss A; Shevach EM
Nature; 1987 Apr 2-8; 326(6112):505-7. PubMed ID: 3104795
[TBL] [Abstract][Full Text] [Related]
7. Antigen-specific and antibody-mediated growth inhibition of suppressor T cell hybridomas. Roles of H-2 and the CD3-T cell receptor-alpha/beta complex.
Kuchroo VK; Billings PR; Levine C; Martin CA; Kubo RT; Dorf ME
J Immunol; 1990 Aug; 145(4):1059-65. PubMed ID: 2143205
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and production of IL-2 and B cell stimulatory factor 1/IL-4 in early fetal thymocytes by activation through Thy-1 and CD3.
Tentori L; Pardoll DM; Zuñiga JC; Hu-Li J; Paul WE; Bluestone JA; Kruisbeek AM
J Immunol; 1988 Feb; 140(4):1089-94. PubMed ID: 2893823
[TBL] [Abstract][Full Text] [Related]
9. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
Green-Johnson JM; Szewczuk MR
Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
[TBL] [Abstract][Full Text] [Related]
10. Thy-1-negative and Ly-1-negative variants of T cells produce interleukin 2 in response to mitogens.
Hollander N
J Immunol; 1987 Jul; 139(2):437-42. PubMed ID: 2885371
[TBL] [Abstract][Full Text] [Related]
11. The cytoplasmic tail of the T cell receptor zeta chain is dispensable for antigen-mediated T cell activation.
Hermans MH; Malissen B
Eur J Immunol; 1993 Sep; 23(9):2257-62. PubMed ID: 8103746
[TBL] [Abstract][Full Text] [Related]
12. Role of Ly-6A/E and T cell receptor-zeta for IL-2 production. Phosphatidylinositol-anchored Ly-6A/E antagonizes T cell receptor-mediated IL-2 production by a zeta-independent pathway.
Codias EK; Fleming TJ; Zacharchuk CM; Ashwell JD; Malek TR
J Immunol; 1992 Sep; 149(6):1825-52. PubMed ID: 1387661
[TBL] [Abstract][Full Text] [Related]
13. Modulation of TCR-mediated signaling pathway by thymic shared antigen-1 (TSA-1)/stem cell antigen-2 (Sca-2).
Saitoh S; Kosugi A; Noda S; Yamamoto N; Ogata M; Minami Y; Miyake K; Hamaoka T
J Immunol; 1995 Dec; 155(12):5574-81. PubMed ID: 7499840
[TBL] [Abstract][Full Text] [Related]
14. sgp-60, a signal-transducing glycoprotein concerned with T cell activation through the T cell receptor/CD3 complex.
Reiser H
J Immunol; 1990 Oct; 145(7):2077-86. PubMed ID: 1975823
[TBL] [Abstract][Full Text] [Related]
15. Regulation of nuclear factor-kappa B and activator protein-1 activities after stimulation of T cells via glycosylphosphatidylinositol-anchored Ly-6A/E.
Ivanov V; Fleming TJ; Malek TR
J Immunol; 1994 Sep; 153(6):2394-406. PubMed ID: 7915738
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic loss of activation pathways in a T-cell receptor alpha-chain deletion variant of a cytolytic T-cell clone.
Schmitt-Verhulst AM; Guimezanes A; Boyer C; Poenie M; Tsien R; Buferne M; Hua C; Leserman L
Nature; 1987 Feb 12-18; 325(6105):628-31. PubMed ID: 2880301
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
[TBL] [Abstract][Full Text] [Related]
18. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
19. Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation.
Bamezai A; Goldmacher V; Reiser H; Rock KL
J Immunol; 1989 Nov; 143(10):3107-16. PubMed ID: 2572642
[TBL] [Abstract][Full Text] [Related]
20. Activation properties of T cell receptor-gamma delta hybridomas expressing diversity in both gamma- and delta-chains.
Marusić-Galesić S; Pardoll DM; Saito T; Leo O; Fowlkes BJ; Coligan J; Germain RN; Schwartz RH; Kruisbeek AM
J Immunol; 1988 Jan; 140(2):411-8. PubMed ID: 3257236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
